LESSON II: Evaluation and Management of Infectious Disease

ASSIGNMENT 11.1: COVID-19 Evaluation and Management



At the end of this lesson, you will be able to demonstrate advanced skills in physical assessment, pharmacology, and therapeutic nursing interventions of COVID-19. (CO7)

Before you begin this assignment, review the following simulation:

COVID-19 Primer Virtual Patient Simulation

Assignment Guidelines

Discuss the physical assessment, pharmacology, and therapeutic interventions for a patient presenting COVID-19.

Your response should be 300-500 words. Be sure to write using APA format. Cite at least two peer-reviewed, reliable sources that you used to develop your plan. Provide both in-text citations and full APA citations of the sources.

Read the following selection on COVID-19:

Pringle, J. C., Leikauskas, J., Ransom-Kelley, S., et al. (2020). COVID-19 in a Correctional Facility Employee Following Multiple Brief Exposures to Persons with COVID-19 Vermont, July-August 2020Links to an external site.. MMWR. Morbidity and Mortality Weekly Report, 69(43).

The book used for this class and for this assignment is cited here:

Buttaro, T., Trybulski, J., Bailey, P., & Sandberg-Cook, J. (2021). Primary care: Interprofessional collaborative practice (6th ed.). St. Louis, MO: Elsevier Mosby.

Dains, J., Baumann, L., & Scheibel, P. (2019). Advanced health assessment & clinical diagnosis in primary care (6th ed.). St. Louis, MO: Elsevier Mosby.


Criteria  Expectations

Content Follows directions, answers all questions thoroughly and appropriately.

Grasp of significance       Projects thorough knowledge and critical understanding of the significance of the assignment to professional development as an FNP.

Clarity and LogicAll answers are correct with a clear and logical path to reach a solution to the problem presented.

Terminology       Uses appropriate terminology correctly throughout.


Contains no errors in grammar or spelling. Uses references and cites them properly using APA format.

COVID-19 Evaluation and Management Essay Sample

The Physical Assessment, Pharmacology, And Therapeutic Interventions for A Patient Presenting COVID-19

            Presentation of COVID-19 develops two days to 2 weeks after a person’s exposure to the virus. Physical assessment or examination is one of three pillars of diagnostic evaluation that allows diagnosis confirmation based on history by informing about disease pattern and severity (Dains et al., 2019). It informs the next diagnostic pillar, which involves choosing laboratory investigations. Physical assessment for a COVID-19 patient should take place in a private room with the examiner wearing PPE, including masks, gowns, gloves, respirators, nose, and mouth. The results of the assessment for the patient will most likely be fever, shortness of breath, cyanosis, low blood pressure, and tachypnea. The patient will likely report dry cough, vomiting or diarrhea, fatigue, anosmia, and headache.

            COVID-19 treatment should focus on achieving rapid symptom disappearance, ameliorating severe forms of the disease to prevent death, and limiting interpersonal transmission (Torequl Islam et al., 2020). Pharmacologic interventions for COVID-19 include various classes of drugs, mainly antivirals, anticoagulants, anti-inflammatory agents, and antifibrotics. Remdesivir and favipiravir are the major antiviral drugs that could be prescribed or administered to the patient at the early stages of infection when viral inhibition would be effective (Wiersinga et al., 2020). If the patient is hospitalized, the immunomodulatory agents would effectively prevent disease progression. Anticoagulant heparin would be effective if the patient is at risk of thromboembolic complications. Therapeutic interventions may also include oxygen therapy and ventilatory support. Such interventions are needed when a patient requires supportive management of acute hypoxic respiratory. The patient may also require additional interventions such as short-term neuromuscular blockade with a muscle reluctant such as cisatracurium, prone posting, and use of higher positive end-expiratory pressure for oxygenation. If the patient fails to respond to conventional oxygen therapy, the administration of heated high-flow nasal canula oxygen is recommended (Wiersinga et al., 2020).


Dains, J., Baumann, L., & Scheibel, P. (2019). Advanced health assessment & clinical diagnosis in primary care (6th ed.). St. Louis, MO: Elsevier Mosby.

Torequl Islam, M., Nasiruddin, M., Khan, I. N., Mishra, S. K., Kudrat-E-Zahan, M., Alam Riaz, T., … & Sharifi-Rad, J. (2020). A perspective on emerging therapeutic interventions for COVID-19. Frontiers in Public Health8, 281.

Wiersinga, W. J., Rhodes, A., Cheng, A. C., Peacock, S. J., & Prescott, H. C. (2020). Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): A review. Jama324(8), 782-793.